Provectus Pharm (PVCT) announced their most recent earnings results for the quarter ended in September 2011. They reported actual earnings per share of $-0.06 when they were expecting earnings to be $-0.05 per share. Actual earnings missed estimated earnings by $-0.01 per share. Investors might expect the stock price to fall as earnings were below expectations. Examining previous stock price movement may help to further determine the direction of the share price. Guidance, stock price, and revenue estimates must be considered as well. A total of 1 analyst is currently covering this company.
Decisionpoint (DPSI) reported earnings results for the quarter ended September 2011. Earnings came in at $0.01 per share compared to analyst estimates of $0.05 per share. Earnings were unexpectedly -80.0% lower or $-0.04 per share below estimates. Investors could expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 1 analyst is currently covering this company.
Lucas Energy, Inc (LEI) announced their most recent earnings results for the quarter ended in September 2011. They reported actual earnings per share of $-0.11 when they were expecting earnings to be $-0.05 per share. Earnings were unexpectedly -120.0% lower than estimated. Investors might expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 1 analyst is currently covering this company. Shares of LEI traded higher by 4.12% or $0.1/share to $2.53. In the past year, the shares have traded as low as $1.04 and as high as $5.23. On average, 309713 shares of LEI exchange hands on a given day and today's volume is recorded at 18000.
Biodelivery Sciences International, Inc (BDSI) announced their most recent earnings results for the quarter ended in September 2011. They reported actual earnings per share of $-0.17 when they were expecting earnings to be $-0.21 per share. Actual earnings beat estimated earnings by $0.04 per share. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. There are currently 2 analysts covering this firm. Investors can look to their reports for more information. Shares of BDSI traded higher by 1.21% or $0.0099/share to $0.83. In the past year, the shares have traded as low as $0.77 and as high as $4.05. On average, 339719 shares of BDSI exchange hands on a given day and today's volume is recorded at 8771.
Applied Dna Sci (APDN) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $0.0 per share, and the company reported $-0.01 per share. Earnings were unexpectedly 0.0% lower than estimated. Investors could expect the stock price to fall as earnings were below expectations. Examining previous stock price movement may help to further determine the direction of the share price. Guidance, stock price, and revenue estimates must be considered as well. There is currently 1 analyst covering this firm. Investors can look to their reports for more information.
